Abstract
Integrins play an important role in haematopoietic stem cell (HSC) maintenance in the bone marrow niche. Here, we demonstrate that Periostin (Postn) via interaction with Integrin-αv (Itgav) regulates HSC proliferation. Systemic deletion of Postn results in peripheral blood (PB) anaemia, myelomonocytosis and lymphopenia, while the number of phenotypic HSCs increases in the bone marrow. Postn−/− mice recover faster from radiation injury with concomitant loss of primitive HSCs. HSCs from Postn−/− mice show accumulation of DNA damage generally associated with aged HSCs. Itgav deletion in the haematopoietic system leads to a similar PB phenotype and HSC-intrinsic repopulation defects. Unaffected by Postn, Vav-Itgav−/− HSCs proliferate faster in vitro, illustrating the importance of Postn-Itgav interaction. Finally, the Postn-Itgav interaction inhibits the FAK/PI3K/AKT pathway in HSCs, leading to increase in p27Kip1 expression resulting in improved maintenance of quiescent HSCs. Together, we demonstrate a role for Itgav-mediated outside-in signalling in regulation of HSC proliferation and stemness.
Integrins regulate haematopoietic stem cell (HSC) homeostasis and engraftment into the bone marrow (BM) niche upon transplantation. Here, the authors show that HSC quiescence and function in the BM is regulated by the interaction of PERIOSTIN and INTEGRIN αv and subsequent increase in p27Kip1.
Haematopoietic stem cells (HSCs) respond to signals from their niche through a repertoire of cell surface receptors, of which integrins constitute a very important class1. Integrins not only aid in cell-extracellular matrix (ECM) and cell–cell adhesion, but are also known to transduce extracellular signals that affect cell fate2. Integrins are a class of heterodimeric trans-membrane receptors composed of an α- and a β-chain, consisting of a large extracellular domain, a single pass trans-membrane domain and a smaller intracellular domain3. Integrins bind to ECM molecules in addition to a variety of cytokines, growth factors, proteases and proteins expressed on the surface of adjacent cells4. HSCs express a variety of integrins, which play important roles in their maintenance within the bone marrow (BM) niche, regulate their egress from the niche, and other functions5,6. For instance, neutralization of VLA4 (α4β1 heterodimer) by blocking antibodies prevent their in vitro attachment to ECM and spleen colony formation in vivo7,8.
Among other integrins, it has been shown that primitive HSCs from murine BM express the integrin-β3 (ref. 9). Thrombopoietin (TPO)-mediated HSC maintenance depends on inside-out signalling through activation of the integrin-αvβ3 (refs 10, 11). Integrin-αvβ3 also plays an important role in vasculogenesis during embryogenesis and tumour development12. Apart from binding vitronectin, Integrin-αvβ3 interacts with other ECM proteins, such as fibrinogen, fibronectin and thrombospondin; growth factors, such as platelet-derived growth factor, insulin and vascular endothelial growth factor receptor-2; and to the protease matrix metalloproteinase13. In addition, Integrin-αvβ3 expression was found to be essential in maintenance of leukaemic stem cells in the MLL-AF9 mouse model14.
Another ECM molecule, Periostin (Postn), also binds to αvβ3 and αvβ5 integrins15 and can induce outside-in signalling via activation of focal adhesion kinase (FAK)16. Postn plays an important role in the development of heart and is involved in many of its pathologies17. Moreover, Postn has been shown to mediate smooth muscle cell migration by FAK mediated signalling via integrins αvβ3 and αvβ5 (ref. 18). Initially identified in a mouse osteoblastic cell line19, Postn is expressed in many cell types, and has more recently been found in multiple cancer tissues such as breast cancer20, lung cancer21, colon cancer22, pancreatic cancer23 and ovarian cancer24 among others25.
Various mechanisms that regulate proliferation have been shown to affect HSC stemness26. Aside from cytokines and growth factors, engagement of integrins, such as binding of VLA4 to vascular cell adhesion molecule and fibronectin, affects HSC proliferation27. Here, we demonstrate that Postn regulates HSC proliferation by direct interaction with Itgav. This interaction results in increased expression of p27Kip1 (Cdkn1b) caused by Postn-mediated inhibition of the FAK/PI3K/Akt pathway, which has been shown to induce quiescence of HSCs (ref. 28). In Postn−/− mice, we observed increased proliferation of haematopoietic stem and progenitor cells (HSPCs) combined with faster functional decline of HSCs following hematopoietic injury, as well as skewing of haematopoiesis in older Postn−/− mice, which has previously been suggested to be a sign of replication stress29. Likewise, we demonstrate that short-term as well as long-term engraftment of HSCs from Itgavfl/fl;Vav-icre mice is decreased, and we also found skewed haematopoietic output of HSCs in these mice. Consistent with recent studies29, our results implicate replication stress in the functional decline of HSCs.
Results
Postn inhibits culture-induced proliferation of BM HSCs
We cultured BM derived Lin−Sca-1+c-kit+ (KLS) cells in serum-free medium containing stem cell factor (SCF) and TPO with or without Postn for up to 5 days. As reported in earlier studies30, KLS cells cultured with SCF/TPO lose their quiescence and start proliferating. We observed a decrease in the expansion of KLS cells cultured in the presence of Postn (≥2 mg ml−1) within 2 days (Fig. 1a, Supplementary Fig. 1A,B). The number of cells harvested after 5 days of culture was enumerated (Supplementary Fig. 1B) and the proportion of phenotypically defined HSC subpopulations was examined by flowcytometry. We observed an increase in the proportion (Fig. 1b) as well as absolute number (Supplementary Fig. 1C) of HSPCs (haematopoietic stem and progenitors; c-Kit+Lin−Sca1+ or KLS cells), short-term (ST-)HSCs (CD150−CD48− KLS cells) and long-term (LT-)-HSCs (CD150+CD48− KLS or SLAM KLS cells). Differences in the cell number could not be attributed to changes in apoptosis as there was no change in Annexin V+ HSCs following culture with/without Postn (Supplementary Fig. 1D). Consistent with the increased proportion of KLS cells, methylcellulose colony-forming unit assays demonstrated that the number of colony-forming unit granulocyte, erythroid, monocyte and megakaryocyte was higher in cultures with Postn (Supplementary Fig. 1E). Using Hoechst 33342 (Ho) staining we found that culture in the presence of Postn resulted in a decreased fraction of cells in G2/M phase of the cell cycle (Supplementary Fig. 1F), while staining with a combination of Hoechst 33342/Pyronin Y (Ho/Py; Fig. 1c) identified a greater proportion of KLS cell progeny from Postn containing cultures to be in the G0 stage of the cell cycle (Fig. 1d). We also examined cell cycle status of the KLS cell fraction within the cells harvested following culture (Supplementary Fig. 1G). Although there was a decrease in the proportion of cells in G0/G1 stage and increase in the cells in S and G2/M stage of the cell cycle, the differences were modest compared with the total cells, suggesting that the cell cycle status of the stem cell population did not change much, while the increase in the stem cell fraction in harvested cells was more pronounced.
We next performed competitive repopulation assays to assess the functional properties of cells cultured with Postn compared with control (Fig. 1e,f). Progeny of 200 CD45.1 KLS cells, cultured with/without Postn was transplanted along with 100,000 CD45.2 whole BM cells (WBMCs) in lethally irradiated CD45.2 animals. Peripheral blood (PB) chimerism was analysed every 4 weeks. We also performed secondary transplantations by grafting 100,000 WBMCs harvested from primary recipients after 12 weeks of transplantation. At 4 weeks following transplantation, PB chimerism in primary recipients transplanted with Postn cultured KLS progeny was lower than in animals grafted with cells cultured without Postn (Fig. 1e). We could not detect any difference in chimerism between primary recipients that received cells cultured with or without Postn 8 and 12 weeks following transplantation. However, chimerism in secondary recipients 12 weeks after transplantation of WBMCs from animals grafted with Postn cultured cells was higher compared with control (Fig. 1f). In addition, we observed higher B-cell chimerism in secondary recipients that received BM from mice transplanted with Postn cultured cells (Supplementary Fig. 1H). Thus, culture of KLS cells with Postn resulted in decreased HSC proliferation and differentiation, which was associated with an increase in phenotypic and functionally defined long-term repopulating HSCs.
Next, we examined if Postn is expressed in the cellular components of HSC niche in the BM (Fig. 1g). As published before31, we sorted osteoblasts (lin−CD45−Ter119−CD51+Sca-1−), mesenchymal stem cells (lin−CD45−Ter119−CD51+Sca-1+) and endothelial progenitor cells (lin−CD45−Ter119−CD31+Sca-1+) to analyse expression of Postn. We observed the highest expression of Postn in the endothelial progenitors. We also observed that the expression of Postn increased in the endothelial progenitors isolated from the BM of irradiated animals when evaluated 24 h post-irradiation (Fig. 1g). Interestingly, we also found elevated levels of Postn transcripts in lin−CD45− cell fraction (Fig. 1h). As Postn is a secreted protein, overall levels of the protein in BM plasma, autocrine regulation of HSC function by HSC-derived Postn cannot be ruled out. However, as our in vitro studies demonstrated that Postn increased maintenance of HSC stemness, autocrine Postn effects, if existed, may not be sufficient to maintain primitive HSCs ex vivo.
Increased proliferation of HSCs in Postn deficient BM
We next evaluated the haematopoietic potential of HSCs from Postn−/− mice. Genotyping was performed to identify Postn−/− animals (Supplementary Fig. 2A) and lack of Postn expression in the BM tissue of the Postn−/− mice was confirmed by quantitative PCR with reverse transcription (qRT-PCR; Supplementary Fig. 2B). BM cells from wild-type (WT) and Postn−/− mice were analysed for the frequency of LT-HSCs (SLAM KLS cells) per million BM cells by flowcytometry (Fig. 2a,b). We observed a higher frequency of SLAM KLS cells per million WBMCs in Postn−/− mice compared with WT mice (Fig. 2b), while there was an overall decrease in BM cellularity in Postn−/− mice (normalized on body weight; Supplementary Fig. 2C). Bromodeoxyuridine (BrdU) incorporation assays demonstrated that an increased proportion of KLS cells were labelled with BrdU in Postn−/− mice (Fig. 2c), suggesting HSPC proliferation. In these experiments wherein BrdU was injected for 3 days, we could not find any difference in BrdU incorporation by LT-HSCs (Supplementary Fig. 2D). As LT-HSCs proliferate at a slower rate, we repeated these experiments with BrdU injection for 7 days. In these experiments, we observed a clear increase in the proportion of LT-HSCs that incorporated BrdU and hence were proliferating (Fig. 2d, Supplementary Fig. 2E).
To assess the functional properties of HSCs from Postn−/− mice, we performed competitive repopulation assays (Fig. 2e–g). In the absence of CD45.2 FVB congenic mice, 50,000 WBMCs from 8-week-old WT or Postn−/− mice were transplanted in sub-lethally (3.5 Gy) irradiated Rag2−/−γC−/− (CD45.2) mice (Fig. 2e). PB chimerism was analysed every 4 weeks and after 12 weeks, 100,000 WBMCs were transplanted in secondary mice. Although the frequency of SLAM KLS cells was higher in Postn−/− mice, we observed lower chimerism in primary (t test: *P=0.02; Fig. 2f) as well as secondary (Fig. 2g) recipients transplanted with Postn−/− WBMCs. We also observed a moderate increase in donor chimerism in the myeloid lineage but a decrease in the B- and T-cell lineage in animals grafted with Postn−/− BM cells (Supplementary Fig. 2F). These results demonstrated that compared with WT HSCs, HSCs in Postn−/− mice proliferate faster, leading to expansion of the phenotypically defined HSC pool, however, with a decreased repopulation ability and a modest bias towards the myeloid lineage.
Altered production of mature blood cells in Postn −/− mice
We next performed PB analysis of the Postn−/− mice in comparison with WT mice to assess the ability of HSCs to maintain homeostasis. In 8-week-old Postn−/− mice (Supplementary Fig. 2G–M), we found a modest decrease in red blood cell count (RBC; Supplementary Fig. 2G) as well as haematocrit values (Supplementary Fig. 2H), but no change in haemoglobin levels (Supplementary Fig. 2I). In addition, Postn−/− mice had more white blood cells (WBCs; Supplementary Fig. 2J) caused by increase in granulocyte numbers (Supplementary Fig. 2K). No change in the proportion of lymphocytes (Supplementary Fig. 2L) or platelets (Supplementary Fig. 2M) was observed. Interestingly, we observed that the differences in the blood counts between WT and Postn−/− mice were more pronounced in 16-week-old mice. We detected a greater increase in WBC counts (Fig. 2h) in 16-week-old Postn−/− mice than in 8-week-old mice. There was a concomitant decrease in the RBC counts (Fig. 2i), haematocrit values (Fig. 2j) and haemoglobin levels (Fig. 2k). In addition, in 16-week-old mice, unlike 8-week-old mice, we found a decrease in lymphocytes in the PB (Fig. 2l) as well as a further increase in granulocyte numbers (Fig. 2m). As in 8-week-old mice, platelet count was not changed even in 16-week-old mice (Supplementary Fig. 2N). Although these results do not present any direct causative link between the lack of Postn and aging, it is noteworthy that aged mice show a similar haematopoietic phenotype, where increased myelopoiesis with decreased lymphopoiesis is observed32. Our experiments also showed decreased expression of Postn in the non-haematopoietic fraction of BM of aged mice (Supplementary Fig. 2O). In addition, multiple mouse models with poor HSC function with faster exhaustion have been reported with this phenotype, as reviewed recently33.
As the haematopoietic phenotype was more pronounced in 16-week compared with 8-week-old Postn−/− mice, we repeated long-term repopulation assays using sorted primitive HSCs from 16-week-old mice to further assess their function (Fig. 2n,o). Sub-lethally (3.5 Gy) irradiated Rag2−/−γC−/− mice were transplanted with 200 primitive HSCs (CD150+CD48−KLS cells) derived from 16-week-old WT or Postn−/− mice. We did not observe any difference in donor-derived chimerism in primary recipients transplanted with HSCs from WT or Postn−/− mice (Fig. 2n). However, donor-derived chimerism in secondary recipients of Postn−/− HSCs was decreased (Fig. 2o). In addition, we observed a lower frequency of donor-derived primitive HSCs than recipient HSCs (Fig. 2p). Further analysis of the cell cycle status of these donor cells showed a marginal decrease in the proportion of primitive HSCs in G0 stage of cell cycle (Fig. 2q, Supplementary Fig. 2P). This suggests poor long-term potential of primitive HSCs derived from 16-week-old Postn−/− mice.
Postn −/− mice recover faster from haematopoietic injury
As our studies suggested poor function of primitive HSCs in Postn−/− mice, we hypothesized that this might affect the ability of HSCs to rescue these animals from radiation injury. To assess this, WT and Postn−/− mice were sub-lethally irradiated and the recovery of the haematopoietic system was followed for 7 weeks by weekly blood cell counts (Fig. 3a–c, Supplementary Fig. 3A–C). A faster recovery of total WBC counts (Fig. 3a), granulocyte counts (Fig. 3b) and haematocrit values (Fig. 3c) were seen at 3 weeks following irradiation in Postn−/− mice. There was a modest increase in the recovery of platelets (Supplementary Fig. 3A), RBC count (Supplementary Fig. 3B), haemoglobin levels (Supplementary Fig. 3C), but no change in lymphocyte recovery in Postn−/− mice compared with WT mice (Supplementary Fig. 3D). As improved haematopoietic recovery was seen despite lower haematopoietic potential of HSCs in Postn−/− mice, we hypothesized that faster haematopoietic recovery might be explained by faster cycling of the haematopoietic progenitors. We therefore analysed the cell cycle status of KLS cells in BM of Postn−/− and WT mice following sub-lethal irradiation (Fig. 3d). On day 14 after sub-lethal irradiation, we observed more proliferative KLS cells in BM of Postn−/− compared with WT mice (Fig. 3d). We also assessed the frequency of the different HSPC populations in the BM of Postn−/− and WT mice 8 weeks after irradiation. Although the number of lin−c-kit+ (Supplementary Fig. 3E) and KLS cells (Supplementary Fig. 3F) in Postn−/− BM was not affected, the proportion of SLAM KLS cells (Fig. 3e) was reduced. Analysis of lineage-committed cells in the BM also demonstrated an increased number of myeloid cells (CD11b/Gr-1) with reduced T- (CD4/CD8) and B- (B220) lymphoid cells (Fig. 3f) in Postn−/− compared with WT mice.
Postn affects HSC proliferation via binding with Itgav
As improved homing potential could cause enhanced long-term engraftment of HSCs cultured with Postn, we first examined whether there was any change in adhesion and migration potential of Postn cultured cells in vitro (Fig. 4a,b). We found no differences in the adhesion of KLS progeny cultured with or without Postn to the BM stromal cell line ST2 (Fig. 4a). We also could not detect any change in their migration towards SDF-1α (Fig. 4b). To further assess BM homing of the Postn cultured cells, lethally irradiated mice were transplanted with the progeny of KLS cells cultured with or without Postn and the proportion of total colony-forming cells (CFCs) transplanted that homed in the BM within 16 h was quantified (Fig. 4c). We found no effect of Postn on the homing potential of KLS progeny.
We next determined if the Itgav (CD51) and Itgb3 (CD61) subunits, which make a heterodimer known to be a binding partner of Postn, were expressed on SLAM KLS cells (Fig. 4d). While more than 70% of SLAM KLS cells expressed Itgav, only 25% expressed Itgb3. Itgavb3 binds specifically to the cyclic Arg-Gly-Asp-D-Phe-Lys (cyclo-RGDfK) peptide34. To determine if Postn binds to Itgavb3, we examined the adhesion of KLS cells, incubated for 3 h with or without Postn, to cyclo-RGDfK coated ultra-low attachment plates (Fig. 4e). Cyclo-RADfK was used as negative control for each experiment. We found decreased attachment of KLS progeny cultured with Postn to cyclo-RGDfK coated plates, compared with control. We then examined if neutralizing Itgav or Itgb3 antibodies could block Postn-induced inhibition of proliferation of KLS cells (Fig. 4f,g). We found that Postn-induced decrease in expansion of HSPCs was inhibited by neutralization of Itgav but not Itgb3 (Fig. 4g). These results demonstrate that Postn binds to Itgav and that signalling via Itgav may be responsible for the inhibition of HSC proliferation caused by Postn.
Decreased HSCs and myeloid bias in Vav-Itgav −/− mice
As neutralizing antibodies against Itgav blocked the inhibitory effect of Postn on HSC proliferation in vitro, we wished to determine if the haematopoietic phenotype found in Postn−/− mice would be phenocopied in mice with Itgav deletion. Universal deletion of Itgav causes perinatal lethality35. Therefore, we conditionally deleted Itgav in the haematopoietic system by crossing Itgavfl/fl mice36 with Vav-iCre mice37 (Supplementary Fig. 4A,B). Litters were born in normal mendelian ratios and appeared healthy. We confirmed the lack of Itgav expression in BM cells by qRT-PCR (Supplementary Fig. 4C). Using flowcytometry, we confirmed that BM KLS cells did not express Itgav protein (Supplementary Fig. 4D). We next assessed PB counts in Vav-iCre+;Itgavfl/fl mice (Vav-Itgav−/−; KO) in comparison with Vav-iCre+;Itgavfl/+ (Vav-Itgav+/−; HT) and Vav-iCre+;Itgav+/+ (Vav-Itgav+/+; WT) mice. In young adults (8 weeks old), we observed increased numbers of total WBCs (Fig. 5a) in Vav-Itgav−/− mice with specifically elevated monocyte (Fig. 5b) and granulocyte (Fig. 5c) counts compared with Vav-Itgav+/+. Like in 16-week-old Postn−/− mice, we observed a decreased lymphocyte count in 8-week-old Vav-Itgav−/− as well as Vav-Itgav+/− mice when compared with Vav-Itgav+/+ mice (Fig. 5d). We observed no change in RBC count (Supplementary Fig. 4E), haematocrit values (Supplementary Fig. 4F), haemoglobin levels (Supplementary Fig. 4G) and platelet counts (Supplementary Fig. 4H). Next, we compared the number of KLS and SLAM KLS cells in BM of 8-week-old KO and WT mice (Fig. 5e). We did not observe any change in total BM cellularity (Supplementary Fig. 4I); however, we observed an increase in the number of KLS (Fig. 5f) as well as SLAM KLS (Fig. 5g) cells. We performed competitive repopulation assays to assess the functional properties of Itgav−/− HSCs (Fig. 5h). First, 10,000 Vav-Itgav−/− or Vav-Itgav+/+ WBMCs along with 90,000 supporting CD45.1 WBMCs were transplanted into lethally irradiated CD45.1 recipients (Fig. 5i,j). As was also seen in Postn−/− WBMC transplantations, we observed lower donor chimerism in primary (Fig. 5i) as well as secondary recipients (Fig. 5j) despite the increased number of SLAM KLS cells in the BM of Vav-Itgav−/− mice. As increased granulocyte and decreased lymphocyte counts in PB was already very obvious at 8 weeks in Vav-Itgav−/− mice, suggesting earlier HSC exhaustion in Vav-Itgav−/− than in Postn−/− mice, we tested whether purified HSCs from these mice had decreased repopulation potential (Fig. 5k,l). Competitive repopulation with 200 KLS cells from Vav-Itgav−/− mice along with 100,000 CD45.1 WBMCs cells into lethally irradiated CD45.1 recipient mice resulted in a lower donor chimerism in primary (Fig. 5k) as well as secondary recipients (Fig. 5l). Transplantation of WBMCs as well as sorted HSCs from Vav-Itgav−/− mice led to higher myeloid lineage reconstitution with reduced B- and T-cell lineage reconstitution (Supplementary Fig. 4J,K), consistent with the observations on PB cell counts from these mice. As haematopoietic system specific deletion of Itgav and systemic deletion of Postn has a very similar effect on haematopoiesis, this strongly supports our hypothesis that Postn-Itgav interaction is important for HSC maintenance.
Postn-unresponsive Vav-Itgav −/− HSCs proliferate faster
As loss of Itgav from HSC might lead to decreased homing of HSC and hence decreased repopulation, we performed in vitro adhesion (Fig. 6a,b) and migration assays (Fig. 6c), as well as in vivo homing assays (Fig. 6d). While, we did not observe any difference in their attachment to ST2 cells (Fig. 6a), we observed a modest decrease in adhesion of Vav-Itgav−/− lin− BM cells to RGDfK coated plates (Fig. 6b). Their migration towards SDF-1α was not affected compared with Vav-Itgav+/+ controls (Fig. 6c). In vivo assays did not show any difference in homing capacity of transplanted Vav-Itgav+/+ or Vav-Itgav−/− haematopoietic progenitors (Fig. 6d).
A second explanation for the decreased repopulation of Vav-Itgav−/− HSC might be loss of stemness due to enhanced proliferation caused by loss of the inhibitory effect of Postn in the BM niche. To test this hypothesis, we first performed Ho/Py staining to quantify the proportion of KLS cells in different stages of the cell cycle (Fig. 6e,f). This analysis revealed an increase in the number of KLS cells in the S as well as the G2/M phase, while the proportion of cells in the G0 and G1 phase was decreased (Fig. 6f). The anti-Itgav antibody blocking studies already suggested the importance of Itgav in mediating action of Postn on HSCs (Fig. 4f,g). This was further substantiated by studies wherein KLS cells from Vav-Itgav+/+ and Vav-Itgav−/− mice were cultured with or without Postn (Fig. 6g,h). Consistent with the antibody blocking studies (Fig. 4f,g), Vav-Itgav+/+ KLS cells expanded less in the presence of Postn (Fig. 6g) and the proportion of KLS cells following 5 days of culture was higher in the presence of Postn (Fig. 6h). However, deletion of the Itgav receptor from the KLS cells prevented the inhibitory effect of Postn on cell proliferation (Fig. 6g), which was associated with a decreased frequency of KLS cells (Fig. 6h). Thus, loss of Itgav does not affect HSPC homing, but causes non-responsiveness to Postn, leading to excessive proliferation and differentiation of HSPC in vivo and in vitro.
Postn induces p27kip1 expression by PI3K and Akt inhibition
We then went on to address the molecular mechanism by which Postn binding to Itgav on HSCs inhibits their proliferation. We first tested the expression of various cell cycle regulators in the KLS cells cultured with or without Postn using qRT-PCR (Fig. 7a). Amongst all the genes tested (CyclinD1, CyclinD2, CyclinE1, CyclinA1, CyclinA2, p16Ink4c, p19Ink4d, p15Ink4b, p57Kip2, Cdk2, Cdk4, Cdk6, p21Cip1, p27Kip1) we found the expression of p27Kip1 increased. We then performed experiments to confirm these results at the protein level. Lineage depleted BM cells were cultured with or without Postn and harvested after 2 days. We examined if Postn affected the expression of p27Kip1 protein in HSCs (Fig. 7b). Flowcytometry analysis for p27Kip1 expression demonstrated that Postn treatment led to elevated levels of p27kip1 in SLAM KLS cells (Fig. 7b). In a variety of cell types, the PI3K/Akt pathway has been shown to regulate cell proliferation by regulating the expression and activity of p27Kip1 (refs 38, 39). Therefore, we examined the phosphorylation status of PI3K (Fig. 7c) and Akt (Fig. 7d) in the SLAM KLS fraction of lin− cells cultured with or without Postn using phospho-specific antibodies. We observed a decrease in phosphorylation of both PI3K and Akt, indicating that Postn inhibited the PI3K/Akt pathway leading to increased expression of p27Kip1 and decreased HSC proliferation. FAKs play important roles in transmitting outside-in integrin signals and act as phosphorylation-regulated signalling scaffolds40. FAKs have been shown to regulate several cellular functions such as proliferation, apoptosis and migration via the PI3K/Akt pathway41. We therefore examined the activation status of FAK in SLAM KLS cells, following culture of lin− BM cells with Postn (Fig. 7e, Supplementary Fig. 5A) using phospho-specific antibodies to detect phosphorylation at different sites in FAK protein. While we did not observe any change in phosphorylation at tyrosine 576 or 577 (Supplementary Fig. 5A, left), there was decreased phosphorylation at tyrosine 397 (Fig. 7e). As some studies have demonstrated that outside-in integrin signalling results in activation of Src, which in turn can activate PI3K/Akt pathway, we also analysed if culture of HSPCs with Postn affected Src phosphorylation. We observed an increase in the phosphorylation status at the activating site (y416; Supplementary Fig. 5B) along with decreased phosphorylation at the de-activating site (y527, Supplementary Fig. 5C). As phosphorylation of both PI3K and Akt was decreased in Postn treated cells, these results indicated the involvement of FAK mediated integrin signalling rather than Src phosphorylation for cell cycle regulation in HSCs by Postn. Consistent with this hypothesis, we observed decreased overall expansion (Fig. 7f) with concomitant increase in the proportion of LT-HSCs (Fig. 7g) when KLS cells were cultured in the presence of a FAK inhibitor, PF-573228, even without addition of Postn. Collectively, these data suggests that binding of Postn to Itgav results in inhibition of the FAK/PI3K/Akt pathway, causing increased expression of p27kip1 and decreased HSC proliferation (Fig. 8).
DNA damage accumulation in young Postn −/− HSCs
Accumulation of DNA damage has been associated with replicative stress, which in turn has been implicated in several age associated haematopoietic disorders42. In aged mice, impaired DNA damage responses have been observed in HSCs43,44. In addition, HSCs with a defect in the DNA damage response pathways, such as in Atm deficient mice, function poorly45. Our results showed that interrupting the Postn-Itgav interaction in Postn−/− as well as Vav-Itgav−/− mice, led to poor functioning of HSCs concomitant with faster rate of proliferation and functional decline. Therefore, we tested if HSCs from young (16 week old) Postn−/− mice showed DNA damage accumulation. SLAM KLS cells from young (16 week old) and old (18 month old) WT mice as well as young (16 week old) Postn−/− mice were sorted and immuno-stained using γH2AX antibodies to identify DNA damage marks (Fig. 9a). First, the proportion of cells with γH2AX foci (at least one) was quantified. Analysis clearly revealed increased proportion of HSCs from young Postn−/− mice with γH2AX foci compared with young WT mice (Fig. 9b). As expected, higher proportion of SLAM KLS cells from old WT mice contained γH2AX foci. We also quantified the extent of DNA damage accumulation in HSCs from each source by enumerating the number of γH2AX foci in individual SLAM KLS cells, isolated from young as well as old WT mice, and young Postn−/− mice (Fig. 9c). We observed increased level of γH2AX foci accumulated in individual HSCs from young Postn−/− mice compared with young WT mice. Again, the highest level of DNA damage accumulation was observed in HSCs from old mice. To exclude the possibility that appearance of γH2AX+ foci could be caused by replication arrest46, we also performed replication protein A (RPA) staining on primitive HSCs isolated from WT or Postn−/− mice (Fig. 9d). Unlike in ultraviolet irradiated control samples, we did not observe RPA staining in either WT or Postn−/− mouse derived HSCs. Thus, greater DNA damage accumulation in HSCs from young Postn−/− mice compared with WT mice suggests that HSC may undergo functional decline as a result of the replicative stress in these cells.
Discussion
We present data demonstrating the importance of Postn-Itgavb3 interaction in the regulation of murine HSC function. The BM of Postn−/− mice contained increased numbers of SLAM KLS cells, which were more proliferative than the WT HSCs. Nevertheless, Postn−/− mice developed progressive anaemia, myelomonocytosis and lymphopenia, and Postn−/− BM cells repopulated the haematopoietic system following grafting poorly. We confirmed these results by haematopoietic tissue-specific deletion of Itgav, which acts a receptor for Postn. Vav-Itgav−/− mice developed pronounced myelomonocytosis and lymphopenia at an earlier age than Postn−/− mice. As was seen in Postn−/− mice, Vav-Itgav−/− BM contained elevated levels of SLAM KLS cells and hyperproliferative KLS cells. In addition, WBMCs and purified HSCs from Vav-Itgav−/− mice poorly reconstituted the haematopoietic system following transplantation. Finally, we demonstrated that the loss of Postn-Itgavb3 interaction caused enhanced HSPC proliferation because of deactivation of the FAK/PI3K/AKT pathway responsible for regulating p27Kip1 expression, leading to increased proliferation and reduced stemness of HSCs in Postn−/− as well as Vav-Itgav−/− mice.
Proliferation and quiescence have been strongly linked to stemness in the haematopoietic system, as well as other stem cell models47,48. For instance, in p21Cip1−/− mice, HSPC proliferation is increasingly reflected in increased numbers of phenotypically defined HSCs in the BM, with, however, loss of cells with long-term culture initiating capacity and long-term repopulating stem cells32. Similar changes have been observed in the haematopoietic system of mice wherein the growth factor independent 1 (Gfi-1)49 or mammalian target of rapamycin (mTOR)50, two upstream regulators of p21Cip1, were deleted from the haematopoietic system. In both of the models, increased proliferation of HSCs, with increased frequency of phenotypically defined HSCs linked with reduced repopulation activity was observed. The discrepancy between the increased number of phenotypic HSCs, identified as SLAM KLS cells, present in the BM of these mice, and their poor repopulation ability is also seen in aged animals51. These mice, like the mice deficient in p21Cip, Gfi-1 or mTOR expression, also display a considerable bias towards myeloid lineage repopulation while poorer lymphoid chimerism was observed. Entry of quiescent HSCs into the cell cycle leads to loss of stemness, which leads to their faster exhaustion52,53. Recent studies using Sirt1 deleted mice, demonstrated that extensive proliferation leads to pre-mature aging and loss of function in HSCs54.
We demonstrated that the deficiency of Postn leads to increased proliferation of HSPCs, and an increase in myelopoiesis and anaemia as early as 8 weeks after birth, which became more pronounced by 16 weeks. At 16 weeks of age, we also found a decreased lymphopoiesis, which combined with the increased myelopoiesis seen, is typical for a poorly functioning haematopoietic system and is also observed during aging55. In addition, purified primitive HSCs from 16-week-old Postn−/− mice exhibited lower LT-repopulation potential and secondary recipients were poorly engrafted. This effect was also seen when the mice were transplanted with WBMCs from 8-week-old Postn−/− mice, even though the proportion of phenotypic primitive HSCs was higher in WBMCs of Postn−/− mice. These results suggest very strongly that the engraftment potential of the HSCs from Postn−/− mice is poorer than from WT mice. Interestingly, we also observed a decrease in ST-repopulation in primary recipients when WBMCs from 8-week-old mice were transplanted showing that the engraftment efficiency of ST-HSCs was also affected in Postn−/− mice. However, when primitive HSCs from 16-week-old mice were transplanted, no differences in the ST- repopulation were seen primarily because of lack of ST-HSCs in the transplanted population. In addition, faster proliferation of donor-derived HSC population in secondary recipients would compensate for ST-HSCs.
Postn is one of the ligands for Itgav-b3 expressed on HSCs. Because blocking Itgav but not Itgb3 with neutralizing antibodies inhibited the effect of Postn on HSCs in vitro, we tested whether the haematopoietic defects seen in Postn−/− mice would be recapitulated in mice wherein Itgav was specifically deleted in haematopoietic cells. As seen in the Postn−/− mice, accelerated loss of stemness was also observed in Vav-Itgav−/− mice. In fact the degree of myeloid skewing was more pronounced in Vav-Itgav−/− mice, compared with Postn−/− mice. In both Postn−/− as well as Vav-Itgav−/− mice, an increase in SLAM KLS cells was found in the BM as early as 8 weeks after birth. However, when whole BM from either 8-week-old Postn−/− or Vav-Itgav−/− mice (young adults) was grafted, decreased long-term repopulation was observed.
There is an extensive body of evidence that engagement of integrins, such as integrin-α4β1, affect HSC function56. Conditional deletion of integrin-α4 (Itga4) in the haematopoietic system resulted in increased circulation of progenitors due to severe loss of HSC maintenance within the BM57. In addition, HSCs that do not express Itga4 repopulate the haematopoietic system very poorly due to loss of homing potential. Here, we demonstrate that loss of Itgav from HSC also caused poorer HSC engraftment. But, in contrast to the studies on Itga4, loss of engraftment of Vav-Itgav−/− HSC was not caused by defects in HSC homing. Recent studies demonstrated a role for Itgb3 in HSC maintenance10,11. These studies demonstrated that inside-out signalling from the TPO receptor activates Itgb3 integrin, which in response to extracellular signals causes an outside-in increased TPO-dependent enhanced haematopoietic reconstitution of HSCs. However, if the loss of Itgb3 expression or its outside-in signalling activity, affects HSC proliferation has not yet been reported.
Our ex vivo studies demonstrated that inhibition of HSC proliferation by Postn, results from binding of Postn to Itgav. Culture of KLS cells in the presence of Postn decreased total cell expansion with, however, preservation of a greater fraction of primitive HSCs. Importantly, Postn did not affect the proliferation of Itgav deficient HSCs, confirming the specificity of the interaction. In addition, Itgav deficient KLS cells proliferated faster than control cells ex vivo as they did in vivo in Postn−/− as well as in Vav-Itgav−/− mice. Likewise, HSC from Postn−/− as well as in Vav-Itgav−/− mice also proliferated more in vivo compared with WT HSCs. We further demonstrated that the faster cycling of Postn−/− HSCs led to faster recovery of the haematopoietic system from radiation injury. However, consistent with the notion that excessive proliferation of HSCs causes exhaustion of the HSC pool, we found depletion of the HSCs in the BM of irradiated animals 8 weeks following the radiation injury.
Accumulation of DNA damage is the hallmark feature of replicative stress in stem cells58. It was recently shown that induction of exit from homeostatic state of dormancy in HSCs directly results in DNA damage accumulation59. As both Postn−/− as well as Vav-Itgav−/− mice contained lower proportions of quiescent HSCs and the haematopoietic progenitors proliferated faster, we tested if this was associated with DNA damage accumulation. Our observation that greater proportion of HSCs from young Postn−/− mice had accumulated DNA damage, demonstrated by an increase in the frequency of γH2AX+ foci, but not RPA32 foci, therefore confirms our hypothesis that the loss of Postn-Itgav interactions caused poor HSC function.
Postn binds to heterodimers of Itgav and multiple β-chains in a variety of cell types16. As discussed above, the effect of Postn on the proliferation of KLS cells in vitro could be blocked only with antibodies against the Itgav chain, not the Itgb3 chain, strongly suggesting that Itgav is responsible for binding of Postn to the heterodimer, while outside-in signalling must occur via the Itgb3 chain. In vascular smooth muscle cells, binding of Postn to Itgavb3 induced phosphorylation of FAK (ref. 16). In contrast, we found reduced phosphorylation of FAK at Tyr397 in SLAM KLS cells in response to Postn in vitro. We demonstrated that inactivation of FAK was associated with inactivation of the PI3K/Akt pathway, which is known to regulate p27Kip1 expression and activity60,61. Inhibition of FAK phosphorylation by the small molecule inhibitor, PF-573228, phenocopied the effect of Postn on the in vitro expansion of KLS cells. Noteworthy, among all the cell cycle regulators tested, the expression of p27kip1 was found to be enhanced in HSPCs treated with Postn. Loss of p27Kip1 leads to increased proliferation of haematopoietic progenitors28, even if the number of long-term repopulating HSC is not affected. Deletion of p57Kip2 in p27kip1−/− HSCs, however, resulted in a decrease in their long-term self-renewal of long-term culture initiating cells62. Our results strongly suggest the involvement of p27Kip1 in Postn-Itgav-mediated regulation of HSC proliferation, but do not rule out the involvement of other factors in this process. Outside-in signalling from integrins can also involve activation of Src, which then activates the PI3K/Akt pathway63. We did indeed observe Src activation, but this in the presence of dephosphorylated PI3K and Akt, indicating that Src activation by Postn-Itgav binding is not responsible for the decreased proliferation observed.
In conclusion, these studies establish Postn-Itgav interaction as an important regulator of HSC proliferation. We provide evidence that outside-in signalling from Itgavb3 in response to Postn causes inactivation of FAK-induced PI3K/Akt signalling, leading to higher expression of the cell cycle regulator p27kip1, which has been shown to induce HSC quiescence28. Either the systemic loss of Postn or haematopoietic specific deletion of Itgav causes excessive proliferation under physiological conditions in vivo, or following injury, causing functional decline and exhaustion of the HSC pool.
Methods
Animals
Six- to eight-week-old FVB/NJ, C57BL/6J-CD45.2 (Centre d'Elevage R. Janvier, Le Genest-St Isle, France), B6.SJL-PTPRCA-CD45.1 (Charles River Laboratories, Raleigh, NC), Rag2−/−γC−/− (from Prof. Chantal Mathieu, Clinical and Experimental Endocrinology, UZ Leuven, Leuven, Belgium) and Postn−/− mice64 were maintained in the animal facility at KU Leuven. Itgavflox/flox mice36 were crossed to Vav-iCre mice (from Thomas Graf, Centre for Genomic Regulation, Barcelona) to obtain Vav-iCre; Itgavfl/fl mice. Genotyping, as described before, was performed on genomic DNA from tail tips as well as from BM cells. Vav-iCre−; Itgavfl/fl and Vav-iCre+; Itgav+/+ littermates were used as controls. During the experiments, mice were maintained in isolator cages, fed with autoclaved acidified water and irradiated food ad libitum. All experiments were approved by the Institutional Ethics Committee of KU Leuven.
Haematopoietic stem cell sorting and culture
BM cells were flushed from femurs and tibiae of mice, pooled, washed twice with phosphate-buffered saline (PBS; Gibco Invitrogen Corp., Carlsbad, CA) containing 0.1% bovine serum albumin (Sigma, St Louis, MO) and filtered through a 40-μm nylon mesh. Lineage positive cells were depleted by magnetic-activated cell sorting (Miltenyi Biotech, Bergisch Gladbach, Germany). The Lineage depleted BM cells were stained with fluorescein isothiocyanate (FITC) conjugated anti-Sca-1, phycoerythrin (PE) conjugated anti-c-kit, allophycocyanin (APC) conjugated anti-Lineage antibody cocktail (0.5 μg ml−1 for each antibody; BD Pharmingen, San Diego, CA, USA). 7-amino actinomycin D (7-AAD; 0.1 μg per sample; Sigma, St Louis, MO) staining was performed to identify viable cells. KLS cells, which were 7-AAD negative, were sorted on a BD FACS Aria III (BD Biosciences, Mountain View, CA). The sorted cells were cultured in round-bottom 96-well plates (BD Biosciences, San Jose, MA) in 100 μl of Stemspan (Stem Cell Technologies) supplemented with 100 ng ml−1 mTPO and 50 ng ml−1 mSCF, with or without rmPostn (0.5–5 mg ml−1; R&D Systems, Minneapolis, MN). Cells were cultured for up to 5 days at 37 °C with 5% CO2.
Competitive repopulation assays
Progeny of 200 CD45.1 KLS cells cultured with/without Postn were transplanted along with 100,000 competitor CD45.2 BM cells. For comparing Vav-iCre+; Itgavfl/fl with Vav-iCre+; Itgav+/+ repopulating cells, 200 freshly isolated KLS cells or 10,000 whole BMCs were transplanted in 8–12-week-old female mice along with 100,000 or 90,000 WBMCs, respectively. Whole BMCs (50,000) derived from FVB/NJ and Postn−/− mice were transplanted in sub-lethally (3.5 Gy) irradiated Rag2−/−γC−/− mice. For functional analysis of primitive HSCs CD150+CD48−KLS cells were fluorescence-activated cell sorting (FACS) sorted from FVB/NJ and Postn−/− mice derived BM cells and 200 cells were transplanted in sub-lethally (3.5 Gy) irradiated Rag2−/−γC−/− mice. PB multilineage chimerism analysis was performed every 4 weeks. After 12 weeks, primary recipients were killed; BM harvested and 100,000 (for Vav-Itgav−/−) or 1 × 106 (for Postn−/−) cells grafted in lethally irradiated secondary recipients. After 3 months, multilineage chimerism in secondary recipients was evaluated. BM of the secondary recipients engrafted with sorted primitive HSCs derived from FVB/NJ and Postn−/− mice was also used for analysis of frequency of donor-derived HSCs. In addition, cell cycle of donor-derived HSCs was performed by additional cell surface staining along with Ho/Py staining.
Radiation recovery experiments
FVB/NJ and Postn−/− mice were irradiated sub-lethally (5 Gy). The extent of haematopoietic injury as well as the recovery was monitored by PB analysis at 1-week intervals for 8 weeks on a scil Vet ABC animal blood counter (Horiba ABX, Montpellier, France). PB levels of RBCs, haematocrit, haemoglobin, total WBCs, monocytes, granulocytes, platelets and lymphocytes were measured.
Flow cytometry
Chimerism and lineage analysis of BM derived cells was performed by flow cytometry. Lineage specific antibodies used were FITC conjugated Mac-1 and Gr-1 for myeloid cells, PECy7 conjugated B220 for B-cells, PE conjugated anti-CD4 and anti-CD8 for T-cells were used in addition to APC conjugated anti-CD45.1 and PerCPCy5.5 conjugated anti-CD45.2 antibodies. All antibodies were procured from BD Pharmingen at were used at 0.25 μg ml−1 concentration. Flow cytometric analysis for primitive HSCs and haematopoietic progenitors was performed using anti-mouse CD48 APC and CD150 PECy7 (0.25 μg ml−1; ebiosciences) along with KLS cells staining (as for sorting). Itgav and Itgb3 expression in the BM derived HSCs was analysed by using α-mItgav and α-mItgb3 along with primitive HSC markers. For intracellular staining, cells already labelled with antibodies against cell surface antigens were fixed with 4% paraformaldehyde, followed by permeabilization with 0.2% saponin. Antibodies against p27kip1 and phospho-specific antibodies against FAK, PI3K, Akt and Src were purchased from Cell signaling Technology Inc. (Beverly, MA, USA), and used at a 1 μg ml−1 concentration. Suitable isotype controls for each antibody were used in all experiments. The cells were analysed by flow cytometry using FACS Canto (BD Biosciences, San Jose, CA).
Cell cycle analysis
BM derived cells were first stained for HSPC markers (Lineage, Sca-1, c-kit) followed by Hoechst 33342 (Ho) alone or in combination with Pyronin Y (PY) staining as described before65. For cell cycle analysis of donor-derived HSCs in secondary recipients, additional staining for CD45.1 was also performed. The cells stained for cell surface markers were incubated with Ho (10 μg ml−1) at 37 °C for 45 min. For Ho/Py staining, this was followed by incubation with 1 μg ml−1 PY and the cells were incubated for additional 30 min. Cell were acquired on FACS Aria III (BD Biosciences) and analysed using FlowJo software (TreeStar, Ashland, OR).
BrdU incorporation assays
BrdU incorporation assays were performed as described before66. Briefly, 1 mg of BrdU per animal was injected intra-peritoneally for 3 (for KLS cells) or 7 (for LT-HSCs) days before analysis. After 3 or 7 days, mice were killed and BM derived cells were analysed for BrdU incorporation with in KLS cell population identified by cell surface staining. Cells stained in the same manner but isolated from an uninjected mouse were used in all cases as negative controls for BrdU staining. The proportion of KLS cells with BrdU uptake was enumerated.
In vitro adhesion assays
For cell adhesion assays, the cells were first labelled with the PKH-26 membrane dye67 according to the manufacturer's instructions (Sigma, St Louis, MO, USA). Freshly sorted or cultured KLS cells were harvested and washed with PBS to remove any protein content. The cells were re-suspended at 1 × 107 per ml of Diluent C. The cell suspension was mixed with an equal volume of 4 mM PKH-26 dye (in Diluent C) for 5 min at room temperature. An equal volume of foetal bovine serum (FBS) was added to stop the reaction and the cells were washed with medium containing 10% FBS. 5 × 104 ST2 cells were plated per well in 24-well plates. 2 × 104 PKH-26 labelled KLS progeny were added per well and incubated for 3 h at 37 °C and 5% CO2. Non-adherent cells were removed and adherent cells were harvested along with the feeder layer. Flowcytometry was used to quantify the labelled cells to compare cell attachment68. Results are represented as percentage of cells adhered.
In vitro migration assays
In vitro trans-well migration assays were performed as described before with slight modifications69. 100,000 lineage depleted BM cells in 200 μl of chemotaxis buffer (RPMI 1640, 1% FBS; (Gibco BRL, Grand Island, NY), and antibiotics) were added to the upper chambers of a 6.5 mm, 3 μm pore size Transwell (Costar, Cambridge, MA) while the lower chambers containing 500 μl of 200 ng ml−1 SDF-1α. Chambers were incubated at 37 °C, 5% CO2 for 3 h. Cells migrating into the lower chamber were counted using FACS (FACS Canto, Becton Dickinson). Per cent migration was determined by calculating the per cent of input cells migrated into the lower chamber.
In vivo homing assay
A protocol published earlier30 originally adapted from previously published reports70,71 was used to examine the homing potential of BM derived HSPCs. One day before transplantation, 6–8-week-old B6.SJL-PTPRCA-CD45.1 mice underwent total body lethal irradiation (10 Gy). 2 × 106 BM cells from Vav-Itgav+/+ or Vav-Itgav−/− mice were injected intravenously into the irradiated mice. Before transplantation, the frequency of CFCs in the transplanted cells were quantified. 16 h after injection, BM from transplanted mice was harvested and donor-derived HSPCs homed in the recipient BM were quantified by colony-forming unit-C assay. For each experiment, a set of 6 mice irradiated but not transplanted was used to quantify left over CFCs in the BM of the irradiated mice. Though negligible (10.64±4.54 per mouse), the values were taken into consideration for making calculation as described below. For CFC assays, 1 × 105 cells were plated in 3 ml methylcellulose using MethoCult GF M3434 medium (Stem Cell Technologies). Each sample was cultured in triplicates at 37 °C with 5% CO2 in air. CFCs were scored after 9–12 days by light microscope. The proportion of total CFCs transplanted that homed in the total recipient BM represents homing.
Quantitative RT-PCR
Total RNA was prepared using the RNA Isolation Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. DNase treatment of RNA was performed using Turbo DNase kit (Ambion, Austin, TX, USA). The purity and the concentration of RNA were assessed using a ND-1000 spectrophotometer (NanoDrop Technologies, USA). 100 ng–1 μg of RNA from each sample was used to synthesize cDNA using Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. qRT-PCR was carried out using Taqman SYBR green universal mix PCR reaction buffer (Applied Biosystems, Foster City, CA). The PCR reactions were carried out in a mastercycler realplex (Eppendorf, Hamburg, Germany) using the following programme: 2 min at 50 °C, 1 min at 95 °C and 40 cycles of 30 s at 95 °C and 30 s at 60 °C. Amplified products from qRT-PCR performed on HSC niche components were also electrophoresed on agarose gel (1.5% in TAE buffer; Sigma Aldrich). The list of primers used is given in Supplementary Table 1.
Immunostaining and fluorescence microscopy
FACS-sorted long-term HSCs (CD150+CD48− KLS cells) were suspended in Stemspan medium. 200 cells per well were plated on fibronectin coated Teflon-printed 10-well glass slides (Matsunmai Glass Industry, Osaka, Japan) as described before30. The cells were fixed for 15 min in 4% paraformaldehyde, permeabilized in 0.1% Triton-X-100 (Sigma) and incubated for 1 h in blocking buffer (10% donkey serum/0.1% Triton-X-100/PBS). The cells were stained with anti-γH2AX or RPA34 antibodies conjugated with alexafluor-488 (2.5 μg ml−1) in addition to Hoechst 33342. Images were captured on a Zeiss AxioImager microscope (Zeiss, Jena, Germany) fitted with an AxioCam MRc5 digital camera. Images were captured using AxioVision AC software (Zeiss) and assembled in Adobe Photoshop.
Statistical analysis
Data are shown as mean±s.e.m. Statistical analysis was performed using a two-tailed Student's t test. P-values <0.05 were considered statistically significant.
Data availability
The authors declare that all data supporting the findings of this study are available within the article and its Supplementary Information Files or from the corresponding author upon reasonable request.
Additional information
How to cite this article: Khurana, S. et al. Outside-in integrin signalling regulates hematopoietic stem cell function via Periostin-Itgav axis. Nat. Commun. 7, 13500 doi: 10.1038/ncomms13500 (2016).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Material
Acknowledgments
The work was supported by an FWO grant (1.2.665.11.N.00) to S Khurana; FWO grants (G085111N10; G0D1715N), BELSP DEV-REPAIR grant, Odysseus funding, CoE-SCIL, PF03 and GOA/11/012 funding from KU Leuven, and the Balcaen fund, Steverlynck fund and Vanwayenberghe fund to CM Verfaillie. Currently, S Khurana is supported by the Indian Institute of Science Education and Research, Thiruvananthapuram. We thank Prof Dominique Bonnet, Prof Louise Purton and Prof Christa Maes for critical review of the manuscript.
Footnotes
Author contributions S.K. designed and performed the experiments, analysed the data and wrote the manuscript; S.S. and J.K.M. provided technical assistance in animal breeding, handling, genotyping and flowcytometry; A.S.-M. produced Postn−/− mice; J.H. provided materials, A.L.-H. provided materials and reviewed the manuscript; C.M.V. supervised all the research and edited the manuscript.
References
- Jones D. L. & Wagers A. J. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 9, 11–21 (2008). [DOI] [PubMed] [Google Scholar]
- Hynes R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002). [DOI] [PubMed] [Google Scholar]
- Luo B. H., Carman C. V. & Springer T. A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619–647 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ginsberg M. H., Partridge A. & Shattil S. J. Integrin regulation. Curr. Opin. Cell Biol. 17, 509–516 (2005). [DOI] [PubMed] [Google Scholar]
- Lapidot T., Dar A. & Kollet O. How do stem cells find their way home? Blood 106, 1901–1910 (2005). [DOI] [PubMed] [Google Scholar]
- Prosper F. & Verfaillie C. M. Regulation of hematopoiesis through adhesion receptors. J. Leukoc. Biol. 69, 307–316 (2001). [PubMed] [Google Scholar]
- Williams D. A., Rios M., Stephens C. & Patel V. P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352, 438–441 (1991). [DOI] [PubMed] [Google Scholar]
- Verfaillie C. M., McCarthy J. B. & McGlave P. B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J. Exp. Med. 174, 693–703 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Umemoto T. et al. Expression of Integrin beta3 is correlated to the properties of quiescent hemopoietic stem cells possessing the side population phenotype. J. Immunol. 177, 7733–7739 (2006). [DOI] [PubMed] [Google Scholar]
- Umemoto T. et al. Integrin-alphavbeta3 regulates thrombopoietin-mediated maintenance of hematopoietic stem cells. Blood 119, 83–94 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishihara J. et al. Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin alphavbeta3. Int. J. Hematol. 99, 393–406 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brooks P. C. et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994). [DOI] [PubMed] [Google Scholar]
- Landen C. N. et al. Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia 10, 1259–1267 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller P. G. et al. In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell 24, 45–58 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillan L. et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62, 5358–5364 (2002). [PubMed] [Google Scholar]
- Karlsson S. et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit. Care 14, R205 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conway S. J. & Molkentin J. D. Periostin as a heterofunctional regulator of cardiac development and disease. Curr. Genomics 9, 548–555 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li G. et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 208, 358–365 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horiuchi K. et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14, 1239–1249 (1999). [DOI] [PubMed] [Google Scholar]
- Shao R. et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 24, 3992–4003 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takanami I., Abiko T. & Koizumi S. Expression of periostin in patients with non-small cell lung cancer: correlation with angiogenesis and lymphangiogenesis. Int. J. Biol. Markers 23, 182–186 (2008). [DOI] [PubMed] [Google Scholar]
- Bao S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5, 329–339 (2004). [DOI] [PubMed] [Google Scholar]
- Baril P. et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 26, 2082–2094 (2007). [DOI] [PubMed] [Google Scholar]
- Ismail R. S. et al. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 60, 6744–6749 (2000). [PubMed] [Google Scholar]
- Ruan K., Bao S. & Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 66, 2219–2230 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orford K. W. & Scadden D. T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9, 115–128 (2008). [DOI] [PubMed] [Google Scholar]
- Papayannopoulou T., Craddock C., Nakamoto B., Priestley G. V. & Wolf N. S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl Acad. Sci. USA 92, 9647–9651 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheng T., Rodrigues N., Dombkowski D., Stier S. & Scadden D. T. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6, 1235–1240 (2000). [DOI] [PubMed] [Google Scholar]
- Flach J. et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512, 198–202 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khurana S. et al. A novel role of BMP4 in adult hematopoietic stem and progenitor cell homing via Smad independent regulation of integrin-alpha4 expression. Blood 121, 781–790 (2013). [DOI] [PubMed] [Google Scholar]
- Khurana S. et al. SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors. Stem Cells 32, 3012–3022 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheng T. et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804–1808 (2000). [DOI] [PubMed] [Google Scholar]
- Khurana S. The effects of proliferation and DNA damage on hematopoietic stem cell function determine aging. Dev. Dyn. 245, 739–750 (2016). [DOI] [PubMed] [Google Scholar]
- Pfaff M. et al. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J. Biol. Chem. 269, 20233–20238 (1994). [PubMed] [Google Scholar]
- Bader B. L., Rayburn H., Crowley D. & Hynes R. O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95, 507–519 (1998). [DOI] [PubMed] [Google Scholar]
- Lacy-Hulbert A. et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl Acad. Sci. USA 104, 15823–15828 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Boer J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314–325 (2003). [DOI] [PubMed] [Google Scholar]
- Cappellini A. et al. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Leukemia 17, 2157–2167 (2003). [DOI] [PubMed] [Google Scholar]
- Motti M. L. et al. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. Am. J. Pathol. 166, 737–749 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitra S. K., Hanson D. A. & Schlaepfer D. D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56–68 (2005). [DOI] [PubMed] [Google Scholar]
- Giancotti F. G. & Ruoslahti E. Integrin signaling. Science 285, 1028–1032 (1999). [DOI] [PubMed] [Google Scholar]
- Rossi D. J., Jamieson C. H. & Weissman I. L. Stems cells and the pathways to aging and cancer. Cell 132, 681–696 (2008). [DOI] [PubMed] [Google Scholar]
- Rossi D. J. et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725–729 (2007). [DOI] [PubMed] [Google Scholar]
- Nijnik A. et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447, 686–690 (2007). [DOI] [PubMed] [Google Scholar]
- Ito K. et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 997–1002 (2004). [DOI] [PubMed] [Google Scholar]
- Ward I. M. & Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276, 47759–47762 (2001). [DOI] [PubMed] [Google Scholar]
- Biteau B. et al. Lifespan extension by preserving proliferative homeostasis in Drosophila. PLoS Genet. 6, e1001159 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rossi L. et al. Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice. Cell Stem Cell 11, 302–317 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hock H. et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002–1007 (2004). [DOI] [PubMed] [Google Scholar]
- Chen C., Liu Y., Liu Y. & Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2, ra75 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morrison S. J., Wandycz A. M., Akashi K., Globerson A. & Weissman I. L. The aging of hematopoietic stem cells. Nat. Med. 2, 1011–1016 (1996). [DOI] [PubMed] [Google Scholar]
- Schaniel C. et al. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood 118, 2420–2429 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scheller M. et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat. Immunol. 7, 1037–1047 (2006). [DOI] [PubMed] [Google Scholar]
- Rimmele P. et al. Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells. Stem Cell Rep. 3, 44–59 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rossi D. J. et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad. Sci. USA 102, 9194–9199 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verfaillie C. M. Adhesion receptors as regulators of the hematopoietic process. Blood 92, 2609–2612 (1998). [PubMed] [Google Scholar]
- Scott L. M., Priestley G. V. & Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell. Biol. 23, 9349–9360 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park Y. & Gerson S. L. DNA repair defects in stem cell function and aging. Annu. Rev. Med. 56, 495–508 (2005). [DOI] [PubMed] [Google Scholar]
- Walter D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549–552 (2015). [DOI] [PubMed] [Google Scholar]
- Hu Q., Klippel A., Muslin A. J., Fantl W. J. & Williams L. T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268, 100–102 (1995). [DOI] [PubMed] [Google Scholar]
- Liang J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8, 1153–1160 (2002). [DOI] [PubMed] [Google Scholar]
- Zou P. et al. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 9, 247–261 (2011). [DOI] [PubMed] [Google Scholar]
- Muller E. J., Williamson L., Kolly C. & Suter M. M. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J. Invest. Dermatol. 128, 501–516 (2008). [DOI] [PubMed] [Google Scholar]
- Malanchi I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85–89 (2012). [DOI] [PubMed] [Google Scholar]
- Arai F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149–161 (2004). [DOI] [PubMed] [Google Scholar]
- Wilson A., MacDonald H. R. & Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194, 1003–1012 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hendrikx P. J., Martens C. M., Hagenbeek A., Keij J. F. & Visser J. W. Homing of fluorescently labeled murine hematopoietic stem cells. Exp. Hematol. 24, 129–140 (1996). [PubMed] [Google Scholar]
- Simmons P. J. et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80, 388–395 (1992). [PubMed] [Google Scholar]
- Zigmond S. H. & Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137, 387–410 (1973). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szilvassy S. J., Meyerrose T. E., Ragland P. L. & Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 98, 2108–2115 (2001). [DOI] [PubMed] [Google Scholar]
- Frenette P. S., Subbarao S., Mazo I. B., von Andrian U. H. & Wagner D. D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc. Natl Acad. Sci. USA 95, 14423–14428 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The authors declare that all data supporting the findings of this study are available within the article and its Supplementary Information Files or from the corresponding author upon reasonable request.